+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Myasthenia Gravis Drug"

Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F - Product Thumbnail Image

Myasthenia Gravis Treatment Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

  • Report
  • May 2024
  • 185 Pages
  • Global
From
Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Myasthenia Gravis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • September 2022
  • 74 Pages
  • Global
From
Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 216 Pages
  • Global
From
Asia Pacific Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 116 Pages
  • Asia Pacific
From
LAMEA Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 116 Pages
  • Africa, Middle East
From
North America Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 107 Pages
  • North America
From
Europe Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Myasthenia Gravis Treatment Market Size, Share & Industry Trends Analysis Report By End-use (Hospitals, Clinics and Others), By Type, By Country and Growth Forecast, 2023 - 2030

  • Report
  • November 2023
  • 116 Pages
  • Europe
From
Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Thumbnail Image

Myasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • October 2023
  • 68 Pages
  • Global
From
Myasthenia Gravis Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access - Product Thumbnail Image

Myasthenia Gravis Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access

  • Report
  • November 2022
  • 31 Pages
  • Global
Myasthenia Gravis Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Myasthenia Gravis Drugs Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2021
  • 112 Pages
  • Global
From
France Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

France Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 70 Pages
  • France
From
China Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

China Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 79 Pages
  • China
From
Germany Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Germany Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 86 Pages
  • Germany
From
Middle East And Africa Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Middle East And Africa Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 79 Pages
  • Middle East, Africa
From
Latin America Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Latin America Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 79 Pages
  • Latin America
From
Italy Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032 - Product Thumbnail Image

Italy Myasthenia Gravis Treatment Market By Drug class, By Age group, By Distribution channel: Opportunity Analysis and Industry Forecast, 2023-2032

  • Report
  • May 2023
  • 80 Pages
  • Italy
From
Loading Indicator

Myasthenia Gravis (MG) is a chronic autoimmune neuromuscular disorder that causes weakness in the skeletal muscles. MG is treated with a variety of drugs, including anticholinesterase drugs, immunosuppressants, and immunomodulators. Anticholinesterase drugs, such as pyridostigmine, are used to increase the availability of acetylcholine at the neuromuscular junction, thereby improving muscle strength. Immunosuppressants, such as azathioprine and cyclosporine, are used to reduce the production of antibodies that attack the neuromuscular junction. Immunomodulators, such as mycophenolate mofetil, are used to modulate the immune system and reduce the production of antibodies. The Myasthenia Gravis Drug market is a subset of the Central Nervous System Drugs market. It is composed of a variety of drugs used to treat MG, including anticholinesterase drugs, immunosuppressants, and immunomodulators. Companies in the Myasthenia Gravis Drug market include Merck, Pfizer, Novartis, GlaxoSmithKline, and Teva Pharmaceuticals. Show Less Read more